primary dysmenorrhea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: 100 unit vitamin E used treatment four times a day from the onset of bleeding and continued through three days for two consecutive menstrual periods. Intervention 2: CAP placebo four t
Treatment - Drugs
Placebo
100 unit vitamin E used treatment four times a day from the onset of bleeding and continued through three days for two consecutive menstrual periods.
CAP placebo four times a day from the onset of bleeding and continued through three days for two consecutive menstrual periods
CAP Fenalgin 46 mg used treatment four times a day from the onset of bleeding and continued through three days for two consecutive menstrual periods.
Sponsors
Vice chancellor for research and Technology, Islamic Azad University Sari Branch
Eligibility
Sex/Gender
Female
Age
18 Years to 26 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are including regular menstruation periods; single girls, range age 18-26 years; moderate or severe degree of dysmenorrhea and exclusion criteria are including being affected by known diseases; signs of womb infections; precedent of phlogiston disease of pelvic, tumor; medicinal and herbal allergies; and appearance of stressful events (divorce and death of parents and relatives) have joined to the study group in recent 6 month and during the treatment period.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Dysmenorrhea. Timepoint: 2 months. Method of measurement: Visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of Primary Dysmenorrhea. Timepoint: 1 month before intervention and 2 months after intervention. Method of measurement: Number of days. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLeila Moslemi
Midwifery group, Faculty of medical science, Islamic Azad University Sari Branch
Outcome results
None listed